Changes in diagnostic evaluation of patients with lung cancer symptoms
One out of five patients with lung cancer symptoms completed diagnostic evaluation. CXR remained first choice, although more completed CT thorax in 2022. GPs may need tools to support risk stratification and choice of imaging.
Authors
- Lisa Maria Sele Sætre (ORCID: https://orcid.org/0000-0002-2029-3301)
- Jens Søndergaard (ORCID: https://orcid.org/0000-0001-7680-9920)
- Dorte Ejg Jarbøl (ORCID: https://orcid.org/0000-0002-3241-4190)
- Kirubakaran Balasubramaniam (ORCID: https://orcid.org/0000-0002-3612-1731)
- Christian Borbjerg Laursen (ORCID: https://orcid.org/0000-0001-6382-9906)
- Sonja Wehberg (ORCID: https://orcid.org/0000-0003-1503-2649)
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
Publication Details
- Journal
- npj Primary Care Respiratory Medicine
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1038/s41533-025-00464-4
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Kræftens Bekæmpelse
- Dansk Kræftforsknings Fond